Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice

Journal of Lipid Research

Volumn 43, Issue 10, 2002, Pages 1602-1609

  Fazio, Sergio ^a,b   Babaev, Vladimir R ^a   Burleigh, Michael E ^b   Major, Amy S ^a   Hasty, Alyssa H ^a   Linton, MacRae F ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Apolipoprotein E; Bone marrow transplant; Hyperlipidemia; Low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA SINUS; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOTTING, WESTERN; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0036793431     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200108-JLR200     Document Type: Article

References (32)

1. Fazio, S., and M. F. Linton. 1996. Murine bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism and atherogenesis. Trends Cardiovasc. Med. 6: 58-65.
2. vanEck, M., N. Herijgers, M. Vidgeon-Hart, N. J. Pearce, P. M. Hoogerbrugge, P. H. E. Groot, and T. J. C. vanBerkel. 2000. Accelerated atherosclerosis in C57B1/6 mice transplanted with apoE-deficient bone marrow. Atherosclerosis. 150: 71-80.
3. Fazio, S., V. R. Babaev, A. B. Murray, A. H. Hasty, K. J. Carter, L. A. Gleaves, J. B. Atkinson, and M. F. Linton. 1997. Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages. Proc. Natl. Acad. Sci. USA. 94: 4647-4652.
4. Ishiguro, H., H. Yoshida, A. S. Major, T. Zhu, V. R. Babaev, M. F. Linton, and S. Fazio. 2001. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J. Biol. Chem. 276: 36742-36748.
5. Hasty, A. H., M. F. Linton, S. J. Brandt, V. R. Babaev, L. A. Gleaves, and S. Fazio. 1999. Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation. 99: 2571-2576.
6. Shimano, H., J. Ohsuga, M. Shimada, Y. Namba, T. Gotoda, K. Harada, M. Katsuki, Y. Yazaki, and N. Yamada. 1995. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J. Clin. Invest. 95: 469-476.
7. Bellosta, S., R. W. Mahley, D. A. Sanan, J. Murata, D. L. Newland, J. M. Taylor, and R. E. Pitas. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
8. Yoshida, H., A. Hasty, A. S. Major, H. Ishiguro, Y. Su, L. A. Gleaves, V. R. Babaev, M. F. Linton, and S. Fazio. 2001. Isoform-specific effects of apolipoprotein E on atherogenesis: Gene transduction studies in apoE-null mice. Circulation. 104: 2820-2825.
9. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apoE deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
10. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
11. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
12. Babaev, V. R., M. B. Patel, C. F. Semenkovich S. Fazio, and M. F. Linton. 2000. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem. 275: 26293-26299.
13. Linton, M. F., A. H. Hasty, V. R. Babaev, and S. Fazio. 1998. Hepatic apoE expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J. Clin. Invest. 101: 1726-1736.
14. VanEck, M., N. Herijgers, J. Yates, N. J. Pearce, P. M. Hoogerbrugge, and T.J. V. Berkel. 1997. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of apoE gene dosage on serum lipid concentrations, betaVLDL catabolism, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17: 3117-3126.
15. Boisvert, W. A., J. Spangerberg, and L. K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
16. Tsukamoto, K., R. K. Tangirala, S. Chun, D. Usher, E. Pure, and D. J. Rader. 2000. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice. Mol. Ther. 1: 189-194.
17. Kawashiri, M., Y. Zhang, D. Usher, M. Reilly, E. Pure, and D. J. Rader. 2001. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor deficient mice. J. Lipid Res. 42: 943-950.
18. -/- mice. Arteriscler. Thromb. Vasc. Biol. 21: 1790-1795.
19. Mazzone, T., L. Pusteinikas, and C. Reardon. 1992. Secretion of apoE by macrophages is accompanied by enhanced cholesterol efflux. Circulation. 86 (Suppl. I): 1-2.
20. Shih, S-J., C. Allan, S. Grehan, E. Tse, C. Moran, and J. M. Taylor. 2000. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem. 275: 31567-31572.
21. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA. 98: 507-512.
22. Huang, Z. H., C. Y. Lin, J. F. Oram, and T. Mazzone. 2001. Serol efflux is mediated by endogenous macrophage apoE expression is independent of ABCA1. Arterioscler. Thromb. Vasc. Biol. 21: 2019-2025.
23. Lin, C. Y., H. W. Duan, and T. Mazzone. 1999. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J. Lipid Res. 40: 1618-1626.
24. Joyce, C. W., M. J. A. Amar, G. Lambert, B. L. Vaisman, B. Paigen, J. Najib-Fruchart, J. R. F. Hoyt, E. D. Neufeld, A. T. Remaley, D. S. Fredrickson, and J. H. B. Brewer. 2002. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA. 99: 407-412.
25. Edgington, T. S., and L. K. Curtiss. 1981. Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. Cancer Res. 41: 3786-3788.
26. Hui, D. Y., J. A. Harmony, T. L. Innerarity, and R. W. Mahley. 1980. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J. Biol. Chem. 255: 11775-11781.
27. de Bont, N., M. G. Netea, P. N. Demacker, I. Verschueren, B. J. Kullberg, K. W. van Dijk, J. W. van der Meer, and A. F. Stalenhoef. 1999. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40: 680-685.
28. de Bont, N., M. G. Netea, P. N. Demacker, B. J. Kullberg, J. W. van der Meer, and A. F. Stalenhoef. 2000. Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur. J. Clin. Invest. 30: 818-822.
29. Roselaar, S. E., and A. Daugherty. 1998. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J. Lipid Res. 39: 1740-1743.
30. Barger, S. W., and A. D. Harmon. 1997. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388: 878-881.
31. Laskowitz, D. T., A. D. Thekdi, S. D. Thekdi, S. K. Han, J. K. Myers, S. V. Pizzo, and E. R. Bennett. 2001. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp. Neurol. 167: 74-85.
32. Tangirala, R. K., D. Pratico, G. A. FitzGerald, S. Chun, K. Tsukamoto, C. Maugeais, D. C. Usher, E. Pure, and D.J. Rader. 2001. Reduction of isoprostanes and regression of advanced atherosclerosis by apoliprotein E. J. Biol. Chem. 276: 261-266.